Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.17, $0.01 better than the analyst estimate of $0.16. Revenue for the quarter came in at $445 million versus the consensus estimate of $448.89 million.

GUIDANCE:

• Allscripts sees FY2019 EPS of $0.65-$0.70, versus the consensus of $0.68.
• Full year 2019 bookings(1) between $1,050 million and $1,100 million, up from prior outlook of between $900 million and $1,000 million

For earnings history and earnings-related data on Allscripts (MDRX) click here.